Validation of the Russian version of neurological disorders depression inventory for epilepsy (NDDI-E).

Depression screening Epilepsy Hospital Anxiety and Depression Scale Major depressive episode Mini-International Neuropsychiatric Interview The Neurological Disorders Depression Inventory for Epilepsy

Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
12 2020
Historique:
received: 03 08 2020
revised: 25 09 2020
accepted: 28 09 2020
pubmed: 28 11 2020
medline: 15 4 2021
entrez: 27 11 2020
Statut: ppublish

Résumé

To translate and validate the English version of the Neurologic Depression Disorders Inventory in Epilepsy (NDDI-E) into the Russian language as an instrument for rapid detection of major depressive episodes (MDE) for patients with epilepsy (PWE) from Russian Federation. One hundred and 75 consecutive PWE were included in the study. All patients were assessed with Mini-International Neuropsychiatric Interview (MINI 6.0.0), Hospital Anxiety and Depression Scale (HADS) and the Russian version of NDDI-E. Chi-square, Fisher's exact and Mann-Whitney tests were used to compare PWE with and without MDE. We analyzed internal structural validity, external validity, and receiver operator characteristics. None of the participants had any difficulties in understanding the questions of NDDI-E. The internal consistency of the inventory was satisfactory (Cronbach's ά = 0.856). Correlation between the NDDI-E and the HADS scores was moderate (r = 0.64, P < 0.001), indicating acceptable external validity. NDDI showed good capacity to detect MDE, with area under the curve of 0.919 (95% CI = 0.868-0.955; standard error: 0.019; P < 0.001). An optimal cut-off point with the highest Yuden's index (J = 0.699) was  > 12. At this point NDDI-E showed sensitivity of 88.16% (95% CI = 78.7%-94.4%), specificity of 81.82% (95% CI = 72.8%-88.9%), positive predictive value of 59.3% (95% CI = 48.8%-69.0%), negative predictive value of 95.8% (95% CI = 92.5%-97.7%). Russian version of NDDI-E is an affordable and fast screening tool with a good combination of sensitivity and specificity.

Identifiants

pubmed: 33246233
pii: S1525-5050(20)30729-0
doi: 10.1016/j.yebeh.2020.107549
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107549

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interest None

Auteurs

Mikhail Zinchuk (M)

Research and Clinical Center for Neuropsychiatry, Moscow, Russian Federation. Electronic address: mzinchuk@mail.ru.

Georgii Kustov (G)

Research and Clinical Center for Neuropsychiatry, Moscow, Russian Federation.

Evgenii Pashnin (E)

Research and Clinical Center for Neuropsychiatry, Moscow, Russian Federation.

Anna Gersamia (A)

Research and Clinical Center for Neuropsychiatry, Moscow, Russian Federation.

Flora Rider (F)

Research and Clinical Center for Neuropsychiatry, Moscow, Russian Federation.

Alexander Yakovlev (A)

Research and Clinical Center for Neuropsychiatry, Moscow, Russian Federation; Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russian Federation.

Alla Guekht (A)

Research and Clinical Center for Neuropsychiatry, Moscow, Russian Federation; Pirogov Russian National Research Medical University, Moscow, Russian Federation.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH